NCT02491788View on ClinicalTrials.gov

Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers

PHASE4CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Sleep Disorder, Shift-Work
Interventions
DRUG

Suvorexant

DRUG

Placebo

Trial Locations (1)

94304

VA Palo Alto Health Care System, Palo Alto

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Stanford University

OTHER

lead

VA Palo Alto Health Care System

FED

NCT02491788 - Examination of the Effectiveness of Suvorexant in Improving Daytime Sleep in Shift Workers | Biotech Hunter | Biotech Hunter